Clinical Trials Directory

Trials / Terminated

TerminatedNCT00286663

Autoimmune Hepatitis Study

Evaluation of the Cellular Immune Response in Patients With Anti-SLA/LP- or Anti-LKM-Positive Autoimmune Hepatitis

Status
Terminated
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
University of Rochester · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to determine the role special antibodies play in possibly identifying Autoimmune Hepatitis through the following: Identify the response of specific T cells to antibodies and Monitor the response of the cells that regulate the immune system

Detailed description

The object of this protocol is to characterize and monitor auto antigen-specific T cell responses in blood and liver biopsies of patients with anti-SLA/LP or anti-LKM-positive autoimmune hepatitis. The results will provide insight into the pathogenesis of autoimmune hepatitis and the monitoring of auto antigen-specific T cell reactivity in correlation to disease exacerbation and therapy.

Conditions

Timeline

Start date
2006-01-01
Completion
2008-06-01
First posted
2006-02-03
Last updated
2008-07-09

Source: ClinicalTrials.gov record NCT00286663. Inclusion in this directory is not an endorsement.